GHK-Cu Injections for Women: What to Expect
The copper peptide behind the blue serums, explained for women who want firmer, better-organized skin after 35: how it works, what the research actually shows, injectable vs. topical, and how a physician-prescribed cycle runs.
In this article
Key Takeaways
- GHK-Cu is a copper-binding tripeptide your body already makes. It acts as a repair signal for skin and connective tissue, and measured levels fall steadily from the twenties onward.
- Its best-supported effects are on collagen and elastin production, skin firmness, and wound repair. The strongest human data comes from topical trials; injectable use rests on mechanism, animal data, and clinical experience.
- Injectable GHK-Cu reaches skin everywhere through the bloodstream. Topical serums act only where they are applied and are limited by how much crosses the skin barrier.
- Most women notice texture and hydration changes in 2 to 4 weeks; firmness changes take 8 to 12 weeks of consistent use.
- At Vael, GHK-Cu is prescribed by a licensed physician after a health screening and compounded by an FDA-registered 503A pharmacy. It is not FDA-approved for any indication.
Quick Facts
Full name
Glycyl-L-histidyl-L-lysine : copper(II), or copper tripeptide-1
What it is
A three-amino-acid peptide bound to a copper ion; naturally present in plasma and skin
Discovered
1973, Dr. Loren Pickart, University of California, San Francisco
Best-supported effects
Collagen and elastin synthesis, skin firmness and elasticity, wound repair
How it is given at Vael
Subcutaneous injection, prescribed by a licensed physician
What ships
10 mg/mL, 5 mL vial, a one-month supply, ready to use
What GHK-Cu is (and why your skin already knows it)
If you have seen a blue serum on a dermatologist's shelf or a "copper peptide" tag on a skincare video, you have met GHK-Cu. Before it was a skincare ingredient it was a discovery in a lab: in 1973 the biochemist Loren Pickart found that plasma from young adults could make aged liver cells behave more like young ones, and spent the following years isolating the molecule responsible. It turned out to be almost absurdly small: three amino acids (glycine, histidine, lysine) with an unusually strong grip on copper.
That molecule is GHK-Cu, and your body makes it. It circulates in plasma, shows up in saliva and urine, and is released from the skin's own structural proteins when tissue is injured. Pickart's group measured roughly 200 ng/mL in 20-year-olds and about 80 ng/mL by age 60, a decline of about 60 percent. That curve tracks the changes most women start noticing in their mid-thirties: skin that is a little slower to bounce back, fine lines that stay put, a loss of that even, lit-from-within quality.
The interesting question is not whether GHK-Cu does something in skin. The topical trials settled that. The question is what happens when you restore it systemically, through a prescribed injection, rather than applying a small amount to your face. That is what this guide is about.
Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences. 2018;19(7):1987. View study
How GHK-Cu works on skin
FIGURE 1 · GHK-CU SIGNALING PATHWAY
GHK-Cu: Mechanism of Action
GHRH receptor agonism and somatotropic axis regulation
GHRH
Growth Hormone-Releasing Hormone
GHK-Cu
29-aa GHRH fragment · t½ = 10-12 min
GHRH Receptor (GHRH-R)
Gαs → adenylyl cyclase → ↑cAMP → PKA → GH exocytosis
Somatostatin (SST)
Released when GH rises · Bypassed by exogenous HGH
Growth Hormone (GH)
22 kDa · pulsatile release · binds GHR
IGF-1 Synthesis
GH → JAK2/STAT5b → IGF1 gene → IGF-1 secretion
Figure 1. GHK-Cu Signaling Pathway
GHK-Cu, a 29-amino acid fragment of endogenous GHRH, binds the GHRH receptor on anterior pituitary somatotrophs, triggering the Gαs/cAMP/PKA cascade that releases growth hormone in physiologic pulses. Unlike exogenous HGH, this mechanism preserves somatostatin negative feedback, maintaining the body's natural safety brake. GH then acts on hepatocytes via JAK2/STAT5b to produce IGF-1, which drives downstream anabolic effects in peripheral tissues.
Adapted from general endocrine physiology. GHK-Cu (Geref) was FDA-approved 1997, discontinued 2008 for manufacturing reasons, not safety.
The repair signal your skin is built to answer
GHK is what scientists call a matrikine: a fragment released from a larger structural protein (SPARC) when the extracellular matrix is damaged. Your skin uses it as an alarm. When the signal goes out, fibroblasts multiply, collagen and elastin production rises, new capillaries form, and immune cells arrive to clean up. You have been running this program your whole life every time you got a scrape.
Injectable GHK-Cu raises the level of that same signal throughout the body without waiting for an injury. Fibroblasts in your face, neck, chest, and hands all receive it. That is the practical difference between a signal your body makes less of every year and one you put back.
Why the copper matters
Copper is not incidental. Lysyl oxidase, the enzyme that cross-links new collagen fibers so they hold their shape, needs copper to work. So does superoxide dismutase, one of the skin's primary antioxidant defenses. GHK-Cu both tells cells to build and hands them the mineral they need to build well. Collagen made without adequate cross-linking is weak and disorganized, which is part of why "more collagen" on its own is not the whole story. Better-organized collagen is.
Collagen, elastin, and the water your dermis holds
In cell and animal work GHK-Cu increases synthesis of type I collagen (structure), type III collagen (flexibility and repair), elastin, and glycosaminoglycans, the molecules that bind water in the dermis. It also increases decorin, a protein that organizes collagen fibers, and nudges the MMP/TIMP balance toward orderly remodeling. Pickart's 2018 review summarizes a 12-week topical trial in which GHK-Cu cream increased collagen production in 70 percent of the women treated, versus 50 percent with a vitamin C cream and 40 percent with retinoic acid. Those were small studies and topical, but they are consistent with the mechanism.
This chart measures reactive oxygen species, the unstable molecules that build up with sun exposure and age and damage skin cells. Researchers stressed human fibroblasts (the WI-38 line, which is derived from lung tissue rather than skin) with hydrogen peroxide, after pretreating some with GHK-Cu at a very low dose (10 nM) and a higher dose (10 μM). Both doses lowered the oxidative-stress signal, shown by the shorter bars on the right. The asterisks mark statistical significance. It is cell-level evidence that GHK-Cu acts as an antioxidant, not only as a collagen booster.
Reactive oxygen species in H₂O₂-stressed WI-38 human fibroblasts pretreated with GHK-Cu at 10 nM and 10 μM (n = 6). Both concentrations reduced oxidative stress versus H₂O₂-only controls (p < 0.05).
Dou Y, Lee A, Zhu L, Morton J, Ladiges W. The potential of GHK as an anti-aging peptide. Aging Pathobiology and Therapeutics. 2020;2(1):58-61. · NIH Public Access
Click image to zoom
What women tend to notice
Set expectations honestly: GHK-Cu is not a filler and it is not a laser. What it changes is the quality of the tissue itself, and that shows up gradually. In our patients, and consistent with the topical literature, the pattern tends to run in this order:
Texture and hydration first. Skin feels smoother and holds moisture better. Makeup sits differently. This is the glycosaminoglycan effect and it is usually the first thing women report. Then firmness. Over two to three months, the jawline, under-eye area, and neck tend to look more defined. This is new, cross-linked collagen and elastin accumulating, and it is slow because collagen turnover is slow. Then evenness. Redness and blotchiness often settle as the inflammatory signals GHK-Cu turns down quiet. Some women see old marks and scars soften as tissue remodels. Beyond the face. Because the injection is systemic, hands, chest, and the skin over the knees and elbows are on the same program. Many women notice their hands before their face.
These panels follow infected skin wounds in mice over 12 days, comparing hydrogels that release GHK-Cu (alone, or combined with an egg-white protein) against a saline-treated control. The photographs show the wound surface at days 0, 3, 6, 9, and 12; the combined GHK-Cu hydrogel closed more than 95 percent of the wound by day 12 while controls reached about 65 percent. The stained cross-sections underneath show the hydrogel groups rebuilding a more complete skin surface with a narrower wound. It is an animal model, a topical gel, and a wound, not cosmetic skin, but it is the clearest picture of what "repair signal" means in practice.
Representative wound photographs and H&E cross-sections over 12 days in an infected-wound mouse model. GHK-Cu hydrogels accelerated closure (over 95% versus about 65% for controls by day 12) and improved epithelialization versus PBS-treated controls.
Click image to zoom
A note on hair
You will see GHK-Cu marketed for hair. There is early research on follicles, but hair regrowth is a drug claim and we do not make it. If hair is your main concern, talk to a dermatologist about evidence-based options first.
Injectable vs. the blue serums
Topical copper peptides are legitimate. Controlled trials of GHK-Cu creams and serums have shown increases in skin thickness, hydration, and elasticity and reductions in fine-line depth. Board-certified dermatologists recommend them, and if you like yours, keep using it. Injectable GHK-Cu does not replace a good serum; it does something the serum cannot.
A serum works where you put it, and only as far as it penetrates. The outer skin barrier exists to keep things out. Even good formulations deliver a limited, variable amount of peptide to the fibroblasts underneath, and only on the surface you applied it to. An injection works everywhere. Subcutaneous GHK-Cu enters the bloodstream and reaches skin across the whole body, along with the connective tissue beneath it. Concentration is controlled by the prescription rather than by a formulation's stability on a shelf.
| Injectable GHK-Cu (Vael) | Topical copper peptide serum | |
|---|---|---|
| What it is | Prescription, compounded by a 503A pharmacy | Over-the-counter cosmetic |
| Where it acts | Skin and connective tissue body-wide | The surface it is applied to |
| How much reaches fibroblasts | Controlled dose via the bloodstream | Limited and variable; depends on penetration |
| Concentration and stability | Set by the prescription; refrigerated vial | Typically 0.01 to 0.05%; oxidation-sensitive |
| Best for | Firmness, tissue quality, face plus hands, neck, and chest | Daily maintenance, texture, fine lines on the face |
| Human evidence | Mechanism, animal data, clinical experience | Several small controlled trials |
| Prescription required | Yes | No |
What it is
- Injectable GHK-Cu (Vael)
- Prescription, compounded by a 503A pharmacy
- Topical copper peptide serum
- Over-the-counter cosmetic
Where it acts
- Injectable GHK-Cu (Vael)
- Skin and connective tissue body-wide
- Topical copper peptide serum
- The surface it is applied to
How much reaches fibroblasts
- Injectable GHK-Cu (Vael)
- Controlled dose via the bloodstream
- Topical copper peptide serum
- Limited and variable; depends on penetration
Concentration and stability
- Injectable GHK-Cu (Vael)
- Set by the prescription; refrigerated vial
- Topical copper peptide serum
- Typically 0.01 to 0.05%; oxidation-sensitive
Best for
- Injectable GHK-Cu (Vael)
- Firmness, tissue quality, face plus hands, neck, and chest
- Topical copper peptide serum
- Daily maintenance, texture, fine lines on the face
Human evidence
- Injectable GHK-Cu (Vael)
- Mechanism, animal data, clinical experience
- Topical copper peptide serum
- Several small controlled trials
Prescription required
- Injectable GHK-Cu (Vael)
- Yes
- Topical copper peptide serum
- No
About the "copper uglies"
Some women who use topical copper peptides report a stretch where skin looks worse before it looks better. The likely explanation is that GHK-Cu turns up the enzymes that clear old collagen (MMPs) as part of remodeling; if clearing briefly outpaces rebuilding, you see it. This is mostly a story about unregulated concentrations in consumer products. With a prescribed, controlled dose delivered systemically, it is not something we see as a pattern, though any new protocol deserves a few weeks of patience.
A realistic week-by-week timeline
Weeks 1-2
Settling in
Injections become routine. Most women feel nothing dramatic; some notice skin holding moisture better toward the end of week two.
Weeks 3-4
Texture and hydration
Smoother texture, better hydration, makeup sitting more evenly. This is the earliest consistent change and the one to look for.
Weeks 5-8
Evenness and early firmness
Redness and blotchiness tend to calm. Under-eye and jawline can start to look more defined as new collagen accumulates.
Weeks 9-12
Firmness and elasticity
The changes most women were hoping for: firmer, more elastic skin on the face, neck, and hands. Collagen turnover is slow; this is why a single month rarely tells the whole story.
Beyond 12 weeks
Maintenance and reassessment
Your physician reviews how you have responded and decides whether to continue or pause. Effects are cumulative while levels are maintained and taper when you stop.
Safety, side effects, and who should wait
GHK-Cu has a long safety record as a naturally occurring molecule that is active at very low concentrations. In practice the side effects we see are minor and local: a small bump, redness, or tenderness at the injection site that resolves within a day or two. Rotating sites (abdomen, thigh, upper arm) keeps this to a minimum. Some women report mild fatigue or light-headedness in the first week; it is uncommon and usually passes.
The honest limits are worth stating plainly. Most of the human data is topical. The injectable evidence is built on strong mechanistic reasoning, animal studies, and clinical experience rather than large randomized trials. Injectable GHK-Cu is not FDA-approved for any indication and is available only as a compounded prescription. And Dr. Pickart, who discovered it and authored much of the review literature, also founded a company that sells copper peptide products, which is a conflict of interest to keep in view even though independent groups have replicated the core findings.
Ideal for
Women in their mid-thirties and beyond who want firmer, better-organized skin and are willing to give a protocol 8 to 12 weeks. Women who already use good topical care and sun protection and want to work from the inside as well. Women who notice their hands, neck, and chest as much as their face.
Consider alternatives if
If you are pregnant, breastfeeding, or planning a pregnancy, GHK-Cu is not appropriate; there is no safety data. If you have a copper metabolism disorder such as Wilson's disease, or a history of cancer, tell your physician; the screening will flag it. If your main goal is hair, or a single deep wrinkle, an in-office treatment may serve you better and we will say so.
Not a replacement for the basics
Daily sunscreen and, for most women, a retinoid remain the evidence-based foundation of skin care. GHK-Cu works alongside them, not instead of them. Wound care, dermatologic care, and any medical treatment your physician has prescribed come first.
How a Vael GHK-Cu cycle runs
GHK-Cu at Vael
Route
Subcutaneous injection
Frequency
Set by your physician; commonly once daily, Monday through Friday
Dose
Per your prescription
Sites
Abdomen, thigh, upper arm, rotated
Vial
10 mg/mL, 5 mL, a one-month supply, ships ready to use
Storage
Refrigerated, 36-46°F (2-8°C); do not freeze
You start with a short health screening. A licensed physician reviews it and decides whether GHK-Cu is appropriate for you; if it is not, you will hear that, and nothing ships. Approved prescriptions are compounded by an FDA-registered 503A pharmacy and delivered ready to use, with dosing instructions from your physician. The solution has a faint blue tint, which is the copper complex and is what you want to see. If it is ever cloudy or discolored, do not use it and contact us.
GHK-Cu is also one half of The Radiance Stack, paired with glutathione for women whose goal is firmness and evenness together, and part of The Total Renewal Stack with NAD+ and glutathione. Your physician can tell you whether a single peptide or a stack makes more sense for what you are after; the 60-second quiz is a reasonable place to start if you are not sure.
Common questions
Related Guides
Continue reading about peptides and protocols that pair well with this guide.
GHK-Cu Injections vs Copper Peptide Serums
The blue serum on your shelf and the prescription vial in a Vael box contain the same molecule and do very different jobs. Here is the honest comparison: what the topical trials actually showed, where a serum stops, what "systemic" does and does not mean, what each costs, and whether it makes sense to use both.
GHK-Cu Results Timeline: Week-by-Week for Women
What women tend to notice in week one, month one, and month three of injectable GHK-Cu, which parts of that timeline the biology actually supports, what speeds results up or slows them down, and what happens when a three-month cycle ends.
How to Inject Peptides at Home: A Calm Guide
A practical, unhurried walkthrough of subcutaneous self-injection for women doing it for the first time: what arrives in the kit, where to inject and how to rotate, the steps in order, what a normal site looks like, and the small habits that make NAD+ comfortable.
Ready to start GHK-Cu?
Physician-prescribed GHK-Cu, compounded by an FDA-registered 503A pharmacy and shipped ready to use.
Medical Disclaimer
The information provided on this website, including all articles, guides, and educational content, is for informational and educational purposes only and is not intended as medical advice, diagnosis, or treatment. Nothing on this site should be construed as a substitute for professional medical advice from a qualified healthcare provider.
The majority of peptides discussed on this site are not approved by the U.S. Food and Drug Administration (FDA) for the indications described. They are classified as bulk drug substances and are available only through a licensed prescribing provider and compounding pharmacy. All treatments require a valid prescription and provider oversight.
The majority of published research on peptide therapies has been conducted in preclinical (animal) models. While early human data is encouraging, comprehensive clinical trial data remains limited for most peptide compounds. Individual results may vary significantly based on health status, injury type, and other factors. No specific outcomes are guaranteed.
Certain peptides discussed on this site are classified as prohibited substances by the World Anti-Doping Agency (WADA) and are banned by major sports organizations including the NFL, NCAA, UFC, NBA, MLB, NHL, and PGA. If you are subject to anti-doping testing, consult your governing body before considering any peptide therapy.
Statements on this website have not been evaluated by the Food and Drug Administration. Products and therapies discussed are not intended to diagnose, treat, cure, or prevent any disease.
© 2026 Wellness MD Group PC DBA Vael. All rights reserved.
Ready to start GHK-Cu?
Physician-prescribed GHK-Cu, compounded by an FDA-registered 503A pharmacy and shipped ready to use. From $229/month.